Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVOMIXX in Celiac Patients on Gluten Free Diet
NCT04160767Phase 4Unknown
- Sponsor
- University of Milan
- Start
- Jan 2019
- Primary completion
- Jul 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Visbiome in celiac disease, sponsored by University of Milan. Status: unknown.
02
Drugs
Visbiome
03
Conditions
celiac disease
Beyond the preview
Go deeper on NCT04160767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04160767.